Oncology Institute (TOI) Competitors $0.55 +0.07 (+13.40%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends TOI vs. PIII, BNR, XGN, ENZ, CCM, PMD, MRAI, ATIP, BRTX, and KDLYShould you be buying Oncology Institute stock or one of its competitors? The main competitors of Oncology Institute include P3 Health Partners (PIII), Burning Rock Biotech (BNR), Exagen (XGN), Enzo Biochem (ENZ), Concord Medical Services (CCM), Psychemedics (PMD), Marpai (MRAI), ATI Physical Therapy (ATIP), BioRestorative Therapies (BRTX), and Kindly MD (KDLY). These companies are all part of the "healthcare" industry. Oncology Institute vs. P3 Health Partners Burning Rock Biotech Exagen Enzo Biochem Concord Medical Services Psychemedics Marpai ATI Physical Therapy BioRestorative Therapies Kindly MD Oncology Institute (NASDAQ:TOI) and P3 Health Partners (NASDAQ:PIII) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, media sentiment, institutional ownership, analyst recommendations, community ranking, dividends and risk. Do analysts prefer TOI or PIII? Oncology Institute currently has a consensus price target of $2.50, suggesting a potential upside of 354.55%. P3 Health Partners has a consensus price target of $2.38, suggesting a potential upside of 1,052.91%. Given P3 Health Partners' higher probable upside, analysts clearly believe P3 Health Partners is more favorable than Oncology Institute.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oncology Institute 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00P3 Health Partners 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has better valuation & earnings, TOI or PIII? P3 Health Partners has higher revenue and earnings than Oncology Institute. Oncology Institute is trading at a lower price-to-earnings ratio than P3 Health Partners, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOncology Institute$324.24M0.13-$83.07M-$0.78-0.71P3 Health Partners$1.27B0.06-$57.77M-$0.84-0.25 Do insiders and institutionals have more ownership in TOI or PIII? 36.9% of Oncology Institute shares are owned by institutional investors. Comparatively, 7.8% of P3 Health Partners shares are owned by institutional investors. 9.5% of Oncology Institute shares are owned by company insiders. Comparatively, 17.9% of P3 Health Partners shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Is TOI or PIII more profitable? P3 Health Partners has a net margin of -6.95% compared to Oncology Institute's net margin of -17.63%. P3 Health Partners' return on equity of -71.31% beat Oncology Institute's return on equity.Company Net Margins Return on Equity Return on Assets Oncology Institute-17.63% -186.83% -34.58% P3 Health Partners -6.95%-71.31%-11.93% Which has more volatility & risk, TOI or PIII? Oncology Institute has a beta of 0.13, meaning that its share price is 87% less volatile than the S&P 500. Comparatively, P3 Health Partners has a beta of 1, meaning that its share price has a similar volatility profile to the S&P 500. Does the MarketBeat Community favor TOI or PIII? Oncology Institute and P3 Health Partners both received 4 outperform votes by MarketBeat users. However, 66.67% of users gave Oncology Institute an outperform vote while only 26.67% of users gave P3 Health Partners an outperform vote. CompanyUnderperformOutperformOncology InstituteOutperform Votes466.67% Underperform Votes233.33% P3 Health PartnersOutperform Votes426.67% Underperform Votes1173.33% Does the media favor TOI or PIII? In the previous week, P3 Health Partners' average media sentiment score of -0.75 beat Oncology Institute's score of -0.86 indicating that P3 Health Partners is being referred to more favorably in the news media. Company Overall Sentiment Oncology Institute Negative P3 Health Partners Negative SummaryP3 Health Partners beats Oncology Institute on 11 of the 16 factors compared between the two stocks. Get Oncology Institute News Delivered to You Automatically Sign up to receive the latest news and ratings for TOI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TOI vs. The Competition Export to ExcelMetricOncology InstituteOffices & clinics of medical doctors IndustryMedical SectorNASDAQ ExchangeMarket Cap$41.56M$1.17B$5.21B$9.14BDividend YieldN/AN/A5.13%4.02%P/E Ratio-0.7112.6489.3417.36Price / Sales0.131.621,240.0477.11Price / CashN/A40.2443.7535.97Price / Book0.717.945.314.79Net Income-$83.07M-$52.07M$122.54M$225.00M7 Day Performance76.45%12.42%0.59%2.62%1 Month Performance161.78%18.99%2.55%3.81%1 Year Performance-74.30%-8.35%25.29%20.10% Oncology Institute Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TOIOncology Institute2.4781 of 5 stars$0.55+13.4%$2.50+354.5%-74.3%$41.56M$324.24M-0.71660Gap UpHigh Trading VolumePIIIP3 Health Partners2.3988 of 5 stars$0.21-0.1%$2.38+1,005.2%-83.0%$77.11M$1.48B-0.26500Positive NewsGap UpHigh Trading VolumeBNRBurning Rock Biotech2.095 of 5 stars$6.55-6.7%N/A-29.7%$67.10M$510.89M-2.181,390Short Interest ↓Positive NewsHigh Trading VolumeXGNExagen4.7657 of 5 stars$3.12-1.6%$7.50+140.4%+101.5%$55.03M$55.75M-3.32220ENZEnzo Biochem1.6871 of 5 stars$0.66-3.4%N/A-51.8%$34.32M$30.31M0.00520Analyst ForecastGap UpCCMConcord Medical Services0.776 of 5 stars$4.51-2.4%N/A-53.2%$19.58M$471.70M0.00970Analyst ForecastGap DownPMDPsychemedicsN/A$2.67-1.8%N/A-20.1%$15.73M$22.10M-5.24140Positive NewsGap DownHigh Trading VolumeMRAIMarpaiN/A$1.00+3.1%$6.00+500.0%-12.1%$13.74M$34.87M-0.38150ATIPATI Physical TherapyN/A$2.63+0.4%N/A-80.3%$11.60M$741.86M-0.145,600High Trading VolumeBRTXBioRestorative Therapies3.9437 of 5 stars$1.56-4.3%$18.00+1,053.8%+25.5%$10.80M$377,000.00-1.027Positive NewsGap UpKDLYKindly MDN/A$1.44+0.8%N/AN/A$8.62M$2.88M0.00N/APositive NewsGap Down Related Companies and Tools Related Companies P3 Health Partners Alternatives Burning Rock Biotech Alternatives Exagen Alternatives Enzo Biochem Alternatives Concord Medical Services Alternatives Psychemedics Alternatives Marpai Alternatives ATI Physical Therapy Alternatives BioRestorative Therapies Alternatives Kindly MD Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TOI) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Oncology Institute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Institute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.